Rabbit anti-CR2 Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A304-423A-T maps to a region between residue 650 to 700 of human Complement Component (3d/Epstein Barr virus) Receptor 2 using the numbering given in entry NP_001868.2 (GeneID 1380).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to CR2 immobilized on solid support.
The epitope recognized by A304-423A maps to a region between residue 650 to 700 of human Complement Component (3d/Epstein Barr virus) Receptor 2 using the numbering given in entry NP_001868.2 (GeneID 1380).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Additional Product Information
Complement receptor type 2 (CR2) is a receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells, and for HNRPU. CR2 participates in B lymphocytes activation [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/P20023].
Alternate Names
C3DR; CD antigen CD21; CD21; Complement C3d receptor; complement component (3d/Epstein Barr virus) receptor 2; complement component 3d receptor 2; complement receptor type 2; CR; Cr2; CVID7; EBV receptor; Epstein-Barr virus receptor; SLEB9
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.